Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid vs Fractional CO2 Laser for Post-Acne Hyperpigmentation
NCT03765021Unknown
- Sponsor
- Cairo University
- Start
- Dec 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of tranexamic acid in Post-inflammatory hyperpigmentation (PIH) (2 arms), sponsored by Cairo University. Primary endpoints: Melanin Index at 3 months, Erythema Index at 3 months and 2 more. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
Post-inflammatory hyperpigmentation (PIH)
Beyond the preview
Go deeper on NCT03765021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03765021.